Answers are grounded in this paper and cite their sources.
Retrospective study reports high gamma pass rates and low dose deviations in helical tomotherapy, indicating both ArcCHECK and Delta4 phantoms provide reliable quality assurance.
The study aims to assess the fluence distribution and point dosage between two phantoms for patient-specific quality assurance on the Tomotherapy system. This was a retrospective study conducted on 15 patients who had radiation using the Helical Tomotherapy Machine (Radixact, Accuray Inc.). We used two phantoms to quantify the fluence produced by the treatment planning system (TPS) and recorded from the machine. The ArcCHECK (Sun-Nuclear) has 1386 diodes placed in a cylindrical configuration. The minimal resolution for this was 7 mm. The second was Delta⁴, supplied by ScandiDos. It has 1069 diode detectors arrayed in a crossed orthogonal configuration with a minimum resolution of 5 mm. All patient plans were transferred to these phantoms to validate the accuracy of treatment plan delivery. We used SunCHECK and ScandiDos Delta⁴ software to compare the fluence produced by the TPS with the fluence measured by the equipment. In ArcCHECK, we used an external ionization chamber, cc13 (IBA dosimetry), whereas in Delta⁴,we employed a central diode detector to quantify point dosage. The mean and standard deviation of the gamma pass percentage with ArcCHECK were 98.3 ± 0.8%, with an average point dose deviation of ± 0.94%. The mean and standard deviation of the gamma pass percentage using Delta⁴ was 99.1 ± 1.6%, while the average point dose deviation was ± 0.60%, both of which were well within the 3% tolerance employing the two phantoms.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: